Bolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01

Bitget2026/09/21 22:04

By:Bitget

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Bolt Biotherapeutics President, CEO, CFO, director William P. Quinn cut his common-stock stake to 25,384 shares.
Sold 17,566 shares in multiple transactions at weighted average prices of $3.77, $3.32, $3.24.
Also bought 637 shares at $3.88, lifting his holdings to 2,950 shares before the later sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bolt Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-396890), on September 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01

You may also like

Crypto prices